nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—ABCB1—kidney cancer	0.16	1	CbGaD
Clopidogrel—CES1—Capecitabine—kidney cancer	0.139	0.24	CbGbCtD
Clopidogrel—CYP3A5—Temsirolimus—kidney cancer	0.0385	0.0662	CbGbCtD
Clopidogrel—ABCB1—Temsirolimus—kidney cancer	0.025	0.0431	CbGbCtD
Clopidogrel—CYP3A4—Everolimus—kidney cancer	0.0222	0.0382	CbGbCtD
Clopidogrel—CYP2C8—Pazopanib—kidney cancer	0.0194	0.0334	CbGbCtD
Clopidogrel—CYP1A2—Pazopanib—kidney cancer	0.015	0.0259	CbGbCtD
Clopidogrel—CYP3A4—Temsirolimus—kidney cancer	0.015	0.0258	CbGbCtD
Clopidogrel—CYP2B6—Sorafenib—kidney cancer	0.0149	0.0256	CbGbCtD
Clopidogrel—CYP3A5—Erlotinib—kidney cancer	0.0144	0.0248	CbGbCtD
Clopidogrel—CYP2C9—Capecitabine—kidney cancer	0.0141	0.0243	CbGbCtD
Clopidogrel—CYP2C8—Erlotinib—kidney cancer	0.0139	0.0239	CbGbCtD
Clopidogrel—CYP3A5—Paclitaxel—kidney cancer	0.0132	0.0227	CbGbCtD
Clopidogrel—ABCB1—Pazopanib—kidney cancer	0.0131	0.0226	CbGbCtD
Clopidogrel—CYP2C8—Paclitaxel—kidney cancer	0.0127	0.0218	CbGbCtD
Clopidogrel—ABCB1—Dactinomycin—kidney cancer	0.012	0.0207	CbGbCtD
Clopidogrel—CYP3A5—Sorafenib—kidney cancer	0.0117	0.0202	CbGbCtD
Clopidogrel—CYP3A5—Vincristine—kidney cancer	0.0114	0.0196	CbGbCtD
Clopidogrel—CYP2C8—Sorafenib—kidney cancer	0.0113	0.0194	CbGbCtD
Clopidogrel—CYP1A2—Erlotinib—kidney cancer	0.0107	0.0185	CbGbCtD
Clopidogrel—ABCB1—Gemcitabine—kidney cancer	0.0095	0.0164	CbGbCtD
Clopidogrel—CYP3A5—Sunitinib—kidney cancer	0.0095	0.0164	CbGbCtD
Clopidogrel—CYP2C19—Sorafenib—kidney cancer	0.00945	0.0163	CbGbCtD
Clopidogrel—ABCB1—Erlotinib—kidney cancer	0.00938	0.0162	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—kidney cancer	0.00903	0.0155	CbGbCtD
Clopidogrel—CYP2C9—Paclitaxel—kidney cancer	0.00885	0.0152	CbGbCtD
Clopidogrel—CYP1A2—Sorafenib—kidney cancer	0.00872	0.015	CbGbCtD
Clopidogrel—ABCB1—Paclitaxel—kidney cancer	0.00859	0.0148	CbGbCtD
Clopidogrel—CYP3A4—Pazopanib—kidney cancer	0.00788	0.0136	CbGbCtD
Clopidogrel—CYP2C9—Sorafenib—kidney cancer	0.00786	0.0135	CbGbCtD
Clopidogrel—ABCB1—Sorafenib—kidney cancer	0.00763	0.0131	CbGbCtD
Clopidogrel—ABCB1—Vinblastine—kidney cancer	0.00753	0.013	CbGbCtD
Clopidogrel—ABCB1—Vincristine—kidney cancer	0.0074	0.0128	CbGbCtD
Clopidogrel—ABCB1—Sunitinib—kidney cancer	0.00618	0.0106	CbGbCtD
Clopidogrel—CYP3A4—Erlotinib—kidney cancer	0.00562	0.00968	CbGbCtD
Clopidogrel—CYP3A4—Paclitaxel—kidney cancer	0.00515	0.00886	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—kidney cancer	0.00463	0.00797	CbGbCtD
Clopidogrel—CYP3A4—Sorafenib—kidney cancer	0.00457	0.00787	CbGbCtD
Clopidogrel—CYP3A4—Vinblastine—kidney cancer	0.00451	0.00777	CbGbCtD
Clopidogrel—CYP3A4—Vincristine—kidney cancer	0.00444	0.00764	CbGbCtD
Clopidogrel—CYP3A4—Sunitinib—kidney cancer	0.0037	0.00638	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—kidney cancer	0.00277	0.00477	CbGbCtD
Clopidogrel—Ticlopidine—CYP1A1—kidney cancer	0.00161	1	CrCbGaD
Clopidogrel—CYP2C19—urine—kidney cancer	0.00133	0.163	CbGeAlD
Clopidogrel—CYP1A2—urine—kidney cancer	0.00108	0.133	CbGeAlD
Clopidogrel—CYP2C9—urine—kidney cancer	0.00103	0.127	CbGeAlD
Clopidogrel—CYP3A4—urine—kidney cancer	0.000783	0.0966	CbGeAlD
Clopidogrel—CYP2C8—renal system—kidney cancer	0.000283	0.0349	CbGeAlD
Clopidogrel—CYP3A5—nephron tubule—kidney cancer	0.000281	0.0346	CbGeAlD
Clopidogrel—CYP2B6—nephron tubule—kidney cancer	0.000279	0.0344	CbGeAlD
Clopidogrel—CYP2C8—kidney—kidney cancer	0.000274	0.0337	CbGeAlD
Clopidogrel—CYP1A2—renal system—kidney cancer	0.000265	0.0326	CbGeAlD
Clopidogrel—CYP3A5—renal system—kidney cancer	0.000255	0.0315	CbGeAlD
Clopidogrel—CYP2B6—renal system—kidney cancer	0.000254	0.0313	CbGeAlD
Clopidogrel—CYP3A5—kidney—kidney cancer	0.000247	0.0304	CbGeAlD
Clopidogrel—CYP2B6—kidney—kidney cancer	0.000245	0.0303	CbGeAlD
Clopidogrel—CYP3A5—cortex of kidney—kidney cancer	0.000241	0.0296	CbGeAlD
Clopidogrel—CYP2B6—gonad—kidney cancer	0.000228	0.0281	CbGeAlD
Clopidogrel—CYP3A4—renal system—kidney cancer	0.000192	0.0236	CbGeAlD
Clopidogrel—CYP3A4—kidney—kidney cancer	0.000185	0.0228	CbGeAlD
Clopidogrel—ABCB1—nephron tubule—kidney cancer	0.000149	0.0184	CbGeAlD
Clopidogrel—ABCB1—renal system—kidney cancer	0.000136	0.0167	CbGeAlD
Clopidogrel—ABCB1—kidney—kidney cancer	0.000131	0.0162	CbGeAlD
Clopidogrel—ABCB1—cortex of kidney—kidney cancer	0.000128	0.0157	CbGeAlD
Clopidogrel—ABCB1—gonad—kidney cancer	0.000122	0.015	CbGeAlD
Clopidogrel—Musculoskeletal discomfort—Gemcitabine—kidney cancer	7.76e-05	0.000366	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Vincristine—kidney cancer	7.75e-05	0.000365	CcSEcCtD
Clopidogrel—Fatigue—Vincristine—kidney cancer	7.74e-05	0.000365	CcSEcCtD
Clopidogrel—Rash—Erlotinib—kidney cancer	7.73e-05	0.000364	CcSEcCtD
Clopidogrel—Dermatitis—Erlotinib—kidney cancer	7.73e-05	0.000364	CcSEcCtD
Clopidogrel—Palpitations—Paclitaxel—kidney cancer	7.72e-05	0.000364	CcSEcCtD
Clopidogrel—Insomnia—Gemcitabine—kidney cancer	7.7e-05	0.000363	CcSEcCtD
Clopidogrel—Eye disorder—Capecitabine—kidney cancer	7.7e-05	0.000363	CcSEcCtD
Clopidogrel—Headache—Erlotinib—kidney cancer	7.68e-05	0.000362	CcSEcCtD
Clopidogrel—Tinnitus—Capecitabine—kidney cancer	7.68e-05	0.000362	CcSEcCtD
Clopidogrel—Loss of consciousness—Paclitaxel—kidney cancer	7.68e-05	0.000362	CcSEcCtD
Clopidogrel—Pain—Vincristine—kidney cancer	7.68e-05	0.000362	CcSEcCtD
Clopidogrel—Constipation—Vincristine—kidney cancer	7.68e-05	0.000362	CcSEcCtD
Clopidogrel—Osteoarthritis—Doxorubicin—kidney cancer	7.68e-05	0.000362	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	7.68e-05	0.000362	CcSEcCtD
Clopidogrel—Paraesthesia—Gemcitabine—kidney cancer	7.65e-05	0.00036	CcSEcCtD
Clopidogrel—Cough—Paclitaxel—kidney cancer	7.63e-05	0.000359	CcSEcCtD
Clopidogrel—Asthenia—Sunitinib—kidney cancer	7.62e-05	0.000359	CcSEcCtD
Clopidogrel—Dyspnoea—Gemcitabine—kidney cancer	7.59e-05	0.000358	CcSEcCtD
Clopidogrel—Nausea—Vinblastine—kidney cancer	7.58e-05	0.000357	CcSEcCtD
Clopidogrel—Nausea—Everolimus—kidney cancer	7.55e-05	0.000356	CcSEcCtD
Clopidogrel—Diarrhoea—Sorafenib—kidney cancer	7.55e-05	0.000356	CcSEcCtD
Clopidogrel—Hypertension—Paclitaxel—kidney cancer	7.54e-05	0.000355	CcSEcCtD
Clopidogrel—Pruritus—Sunitinib—kidney cancer	7.51e-05	0.000354	CcSEcCtD
Clopidogrel—Angiopathy—Capecitabine—kidney cancer	7.47e-05	0.000352	CcSEcCtD
Clopidogrel—Immune system disorder—Capecitabine—kidney cancer	7.44e-05	0.000351	CcSEcCtD
Clopidogrel—Myalgia—Paclitaxel—kidney cancer	7.44e-05	0.00035	CcSEcCtD
Clopidogrel—Arthralgia—Paclitaxel—kidney cancer	7.44e-05	0.00035	CcSEcCtD
Clopidogrel—Chest pain—Paclitaxel—kidney cancer	7.44e-05	0.00035	CcSEcCtD
Clopidogrel—Mediastinal disorder—Capecitabine—kidney cancer	7.42e-05	0.00035	CcSEcCtD
Clopidogrel—Anxiety—Paclitaxel—kidney cancer	7.41e-05	0.000349	CcSEcCtD
Clopidogrel—Hypersensitivity—Dactinomycin—kidney cancer	7.4e-05	0.000349	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	7.39e-05	0.000348	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Gemcitabine—kidney cancer	7.35e-05	0.000346	CcSEcCtD
Clopidogrel—Fatigue—Gemcitabine—kidney cancer	7.34e-05	0.000346	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Vincristine—kidney cancer	7.34e-05	0.000346	CcSEcCtD
Clopidogrel—Dizziness—Sorafenib—kidney cancer	7.3e-05	0.000344	CcSEcCtD
Clopidogrel—Pain—Gemcitabine—kidney cancer	7.28e-05	0.000343	CcSEcCtD
Clopidogrel—Constipation—Gemcitabine—kidney cancer	7.28e-05	0.000343	CcSEcCtD
Clopidogrel—Nausea—Erlotinib—kidney cancer	7.28e-05	0.000343	CcSEcCtD
Clopidogrel—Diarrhoea—Sunitinib—kidney cancer	7.26e-05	0.000342	CcSEcCtD
Clopidogrel—Mental disorder—Capecitabine—kidney cancer	7.22e-05	0.00034	CcSEcCtD
Clopidogrel—Asthenia—Dactinomycin—kidney cancer	7.21e-05	0.00034	CcSEcCtD
Clopidogrel—Confusional state—Paclitaxel—kidney cancer	7.19e-05	0.000339	CcSEcCtD
Clopidogrel—Blood creatinine increased—Doxorubicin—kidney cancer	7.19e-05	0.000339	CcSEcCtD
Clopidogrel—Malnutrition—Capecitabine—kidney cancer	7.17e-05	0.000338	CcSEcCtD
Clopidogrel—Oedema—Paclitaxel—kidney cancer	7.13e-05	0.000336	CcSEcCtD
Clopidogrel—Anaphylactic shock—Paclitaxel—kidney cancer	7.13e-05	0.000336	CcSEcCtD
Clopidogrel—Abdominal pain—Vincristine—kidney cancer	7.1e-05	0.000334	CcSEcCtD
Clopidogrel—Body temperature increased—Vincristine—kidney cancer	7.1e-05	0.000334	CcSEcCtD
Clopidogrel—Liver function test abnormal—Doxorubicin—kidney cancer	7.09e-05	0.000334	CcSEcCtD
Clopidogrel—Infection—Paclitaxel—kidney cancer	7.09e-05	0.000334	CcSEcCtD
Clopidogrel—Flatulence—Capecitabine—kidney cancer	7.07e-05	0.000333	CcSEcCtD
Clopidogrel—Dizziness—Sunitinib—kidney cancer	7.02e-05	0.000331	CcSEcCtD
Clopidogrel—Feeling abnormal—Gemcitabine—kidney cancer	7.02e-05	0.000331	CcSEcCtD
Clopidogrel—Shock—Paclitaxel—kidney cancer	7.02e-05	0.000331	CcSEcCtD
Clopidogrel—Vomiting—Sorafenib—kidney cancer	7.01e-05	0.00033	CcSEcCtD
Clopidogrel—Abdominal pain upper—Doxorubicin—kidney cancer	7.01e-05	0.00033	CcSEcCtD
Clopidogrel—Nervous system disorder—Paclitaxel—kidney cancer	6.99e-05	0.000329	CcSEcCtD
Clopidogrel—Rash—Sorafenib—kidney cancer	6.96e-05	0.000328	CcSEcCtD
Clopidogrel—Dermatitis—Sorafenib—kidney cancer	6.95e-05	0.000327	CcSEcCtD
Clopidogrel—Back pain—Capecitabine—kidney cancer	6.94e-05	0.000327	CcSEcCtD
Clopidogrel—Skin disorder—Paclitaxel—kidney cancer	6.93e-05	0.000326	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	6.91e-05	0.000326	CcSEcCtD
Clopidogrel—Headache—Sorafenib—kidney cancer	6.91e-05	0.000326	CcSEcCtD
Clopidogrel—Muscle spasms—Capecitabine—kidney cancer	6.89e-05	0.000325	CcSEcCtD
Clopidogrel—Diarrhoea—Dactinomycin—kidney cancer	6.88e-05	0.000324	CcSEcCtD
Clopidogrel—Gastritis—Doxorubicin—kidney cancer	6.79e-05	0.00032	CcSEcCtD
Clopidogrel—Vomiting—Sunitinib—kidney cancer	6.75e-05	0.000318	CcSEcCtD
Clopidogrel—Body temperature increased—Gemcitabine—kidney cancer	6.73e-05	0.000317	CcSEcCtD
Clopidogrel—Rash—Sunitinib—kidney cancer	6.69e-05	0.000315	CcSEcCtD
Clopidogrel—Dermatitis—Sunitinib—kidney cancer	6.69e-05	0.000315	CcSEcCtD
Clopidogrel—Abdominal distension—Doxorubicin—kidney cancer	6.68e-05	0.000315	CcSEcCtD
Clopidogrel—Hypotension—Paclitaxel—kidney cancer	6.66e-05	0.000314	CcSEcCtD
Clopidogrel—Headache—Sunitinib—kidney cancer	6.65e-05	0.000313	CcSEcCtD
Clopidogrel—Asthma—Doxorubicin—kidney cancer	6.63e-05	0.000313	CcSEcCtD
Clopidogrel—Anaemia—Capecitabine—kidney cancer	6.63e-05	0.000312	CcSEcCtD
Clopidogrel—Hypersensitivity—Vincristine—kidney cancer	6.62e-05	0.000312	CcSEcCtD
Clopidogrel—Eosinophilia—Doxorubicin—kidney cancer	6.57e-05	0.000309	CcSEcCtD
Clopidogrel—Nausea—Sorafenib—kidney cancer	6.55e-05	0.000309	CcSEcCtD
Clopidogrel—Pancreatitis—Doxorubicin—kidney cancer	6.5e-05	0.000306	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.5e-05	0.000306	CcSEcCtD
Clopidogrel—Angina pectoris—Doxorubicin—kidney cancer	6.46e-05	0.000304	CcSEcCtD
Clopidogrel—Insomnia—Paclitaxel—kidney cancer	6.45e-05	0.000304	CcSEcCtD
Clopidogrel—Vertigo—Capecitabine—kidney cancer	6.44e-05	0.000304	CcSEcCtD
Clopidogrel—Asthenia—Vincristine—kidney cancer	6.44e-05	0.000303	CcSEcCtD
Clopidogrel—Syncope—Capecitabine—kidney cancer	6.43e-05	0.000303	CcSEcCtD
Clopidogrel—Leukopenia—Capecitabine—kidney cancer	6.42e-05	0.000302	CcSEcCtD
Clopidogrel—Paraesthesia—Paclitaxel—kidney cancer	6.4e-05	0.000302	CcSEcCtD
Clopidogrel—Vomiting—Dactinomycin—kidney cancer	6.39e-05	0.000301	CcSEcCtD
Clopidogrel—Bronchitis—Doxorubicin—kidney cancer	6.38e-05	0.000301	CcSEcCtD
Clopidogrel—Dyspnoea—Paclitaxel—kidney cancer	6.36e-05	0.0003	CcSEcCtD
Clopidogrel—Palpitations—Capecitabine—kidney cancer	6.34e-05	0.000299	CcSEcCtD
Clopidogrel—Rash—Dactinomycin—kidney cancer	6.34e-05	0.000299	CcSEcCtD
Clopidogrel—Nausea—Sunitinib—kidney cancer	6.31e-05	0.000297	CcSEcCtD
Clopidogrel—Loss of consciousness—Capecitabine—kidney cancer	6.3e-05	0.000297	CcSEcCtD
Clopidogrel—Pancytopenia—Doxorubicin—kidney cancer	6.3e-05	0.000297	CcSEcCtD
Clopidogrel—Dyspepsia—Paclitaxel—kidney cancer	6.28e-05	0.000296	CcSEcCtD
Clopidogrel—Cough—Capecitabine—kidney cancer	6.26e-05	0.000295	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—kidney cancer	6.2e-05	0.000292	CcSEcCtD
Clopidogrel—Hypertension—Capecitabine—kidney cancer	6.19e-05	0.000292	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—kidney cancer	6.17e-05	0.00029	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.16e-05	0.00029	CcSEcCtD
Clopidogrel—Fatigue—Paclitaxel—kidney cancer	6.15e-05	0.00029	CcSEcCtD
Clopidogrel—Diarrhoea—Vincristine—kidney cancer	6.14e-05	0.000289	CcSEcCtD
Clopidogrel—Asthenia—Gemcitabine—kidney cancer	6.11e-05	0.000288	CcSEcCtD
Clopidogrel—Chest pain—Capecitabine—kidney cancer	6.11e-05	0.000288	CcSEcCtD
Clopidogrel—Myalgia—Capecitabine—kidney cancer	6.11e-05	0.000288	CcSEcCtD
Clopidogrel—Arthralgia—Capecitabine—kidney cancer	6.11e-05	0.000288	CcSEcCtD
Clopidogrel—Constipation—Paclitaxel—kidney cancer	6.1e-05	0.000287	CcSEcCtD
Clopidogrel—Pain—Paclitaxel—kidney cancer	6.1e-05	0.000287	CcSEcCtD
Clopidogrel—Anxiety—Capecitabine—kidney cancer	6.08e-05	0.000287	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.06e-05	0.000286	CcSEcCtD
Clopidogrel—Pruritus—Gemcitabine—kidney cancer	6.03e-05	0.000284	CcSEcCtD
Clopidogrel—Nausea—Dactinomycin—kidney cancer	5.97e-05	0.000281	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—kidney cancer	5.95e-05	0.00028	CcSEcCtD
Clopidogrel—Dizziness—Vincristine—kidney cancer	5.94e-05	0.00028	CcSEcCtD
Clopidogrel—Confusional state—Capecitabine—kidney cancer	5.9e-05	0.000278	CcSEcCtD
Clopidogrel—Feeling abnormal—Paclitaxel—kidney cancer	5.88e-05	0.000277	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.86e-05	0.000276	CcSEcCtD
Clopidogrel—Oedema—Capecitabine—kidney cancer	5.85e-05	0.000276	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Paclitaxel—kidney cancer	5.83e-05	0.000275	CcSEcCtD
Clopidogrel—Diarrhoea—Gemcitabine—kidney cancer	5.83e-05	0.000275	CcSEcCtD
Clopidogrel—Renal failure—Doxorubicin—kidney cancer	5.81e-05	0.000274	CcSEcCtD
Clopidogrel—Infection—Capecitabine—kidney cancer	5.81e-05	0.000274	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—kidney cancer	5.8e-05	0.000273	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—kidney cancer	5.77e-05	0.000272	CcSEcCtD
Clopidogrel—Shock—Capecitabine—kidney cancer	5.76e-05	0.000271	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—kidney cancer	5.75e-05	0.000271	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—kidney cancer	5.75e-05	0.000271	CcSEcCtD
Clopidogrel—Nervous system disorder—Capecitabine—kidney cancer	5.74e-05	0.00027	CcSEcCtD
Clopidogrel—Vomiting—Vincristine—kidney cancer	5.71e-05	0.000269	CcSEcCtD
Clopidogrel—Skin disorder—Capecitabine—kidney cancer	5.68e-05	0.000268	CcSEcCtD
Clopidogrel—Urticaria—Paclitaxel—kidney cancer	5.67e-05	0.000267	CcSEcCtD
Clopidogrel—Rash—Vincristine—kidney cancer	5.66e-05	0.000267	CcSEcCtD
Clopidogrel—Dermatitis—Vincristine—kidney cancer	5.66e-05	0.000266	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—kidney cancer	5.64e-05	0.000266	CcSEcCtD
Clopidogrel—Abdominal pain—Paclitaxel—kidney cancer	5.64e-05	0.000266	CcSEcCtD
Clopidogrel—Body temperature increased—Paclitaxel—kidney cancer	5.64e-05	0.000266	CcSEcCtD
Clopidogrel—Headache—Vincristine—kidney cancer	5.63e-05	0.000265	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Doxorubicin—kidney cancer	5.59e-05	0.000264	CcSEcCtD
Clopidogrel—Epistaxis—Doxorubicin—kidney cancer	5.58e-05	0.000263	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—kidney cancer	5.55e-05	0.000261	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—kidney cancer	5.52e-05	0.00026	CcSEcCtD
Clopidogrel—Hypotension—Capecitabine—kidney cancer	5.47e-05	0.000258	CcSEcCtD
Clopidogrel—Vomiting—Gemcitabine—kidney cancer	5.42e-05	0.000255	CcSEcCtD
Clopidogrel—Rash—Gemcitabine—kidney cancer	5.37e-05	0.000253	CcSEcCtD
Clopidogrel—Dermatitis—Gemcitabine—kidney cancer	5.37e-05	0.000253	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—kidney cancer	5.34e-05	0.000251	CcSEcCtD
Clopidogrel—Headache—Gemcitabine—kidney cancer	5.34e-05	0.000251	CcSEcCtD
Clopidogrel—Nausea—Vincristine—kidney cancer	5.33e-05	0.000251	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.33e-05	0.000251	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—kidney cancer	5.32e-05	0.000251	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—kidney cancer	5.31e-05	0.00025	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—kidney cancer	5.31e-05	0.00025	CcSEcCtD
Clopidogrel—Insomnia—Capecitabine—kidney cancer	5.29e-05	0.000249	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—kidney cancer	5.28e-05	0.000249	CcSEcCtD
Clopidogrel—Paraesthesia—Capecitabine—kidney cancer	5.26e-05	0.000248	CcSEcCtD
Clopidogrel—Hypersensitivity—Paclitaxel—kidney cancer	5.25e-05	0.000248	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—kidney cancer	5.24e-05	0.000247	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—kidney cancer	5.23e-05	0.000246	CcSEcCtD
Clopidogrel—Dyspnoea—Capecitabine—kidney cancer	5.22e-05	0.000246	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—kidney cancer	5.21e-05	0.000245	CcSEcCtD
Clopidogrel—Dyspepsia—Capecitabine—kidney cancer	5.15e-05	0.000243	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—kidney cancer	5.12e-05	0.000241	CcSEcCtD
Clopidogrel—Asthenia—Paclitaxel—kidney cancer	5.12e-05	0.000241	CcSEcCtD
Clopidogrel—Nausea—Gemcitabine—kidney cancer	5.06e-05	0.000238	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Capecitabine—kidney cancer	5.05e-05	0.000238	CcSEcCtD
Clopidogrel—Fatigue—Capecitabine—kidney cancer	5.05e-05	0.000238	CcSEcCtD
Clopidogrel—Pruritus—Paclitaxel—kidney cancer	5.05e-05	0.000238	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—kidney cancer	5.02e-05	0.000237	CcSEcCtD
Clopidogrel—Pain—Capecitabine—kidney cancer	5e-05	0.000236	CcSEcCtD
Clopidogrel—Constipation—Capecitabine—kidney cancer	5e-05	0.000236	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—kidney cancer	4.96e-05	0.000234	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—kidney cancer	4.95e-05	0.000233	CcSEcCtD
Clopidogrel—Diarrhoea—Paclitaxel—kidney cancer	4.88e-05	0.00023	CcSEcCtD
Clopidogrel—Feeling abnormal—Capecitabine—kidney cancer	4.82e-05	0.000227	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—kidney cancer	4.82e-05	0.000227	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—kidney cancer	4.8e-05	0.000226	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Capecitabine—kidney cancer	4.79e-05	0.000225	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—kidney cancer	4.79e-05	0.000225	CcSEcCtD
Clopidogrel—Dizziness—Paclitaxel—kidney cancer	4.72e-05	0.000222	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—kidney cancer	4.65e-05	0.000219	CcSEcCtD
Clopidogrel—Urticaria—Capecitabine—kidney cancer	4.65e-05	0.000219	CcSEcCtD
Clopidogrel—Body temperature increased—Capecitabine—kidney cancer	4.63e-05	0.000218	CcSEcCtD
Clopidogrel—Abdominal pain—Capecitabine—kidney cancer	4.63e-05	0.000218	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—kidney cancer	4.62e-05	0.000218	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—kidney cancer	4.56e-05	0.000215	CcSEcCtD
Clopidogrel—Vomiting—Paclitaxel—kidney cancer	4.53e-05	0.000214	CcSEcCtD
Clopidogrel—Rash—Paclitaxel—kidney cancer	4.5e-05	0.000212	CcSEcCtD
Clopidogrel—Dermatitis—Paclitaxel—kidney cancer	4.49e-05	0.000212	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—kidney cancer	4.47e-05	0.000211	CcSEcCtD
Clopidogrel—Headache—Paclitaxel—kidney cancer	4.47e-05	0.00021	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—kidney cancer	4.44e-05	0.000209	CcSEcCtD
Clopidogrel—Hypersensitivity—Capecitabine—kidney cancer	4.31e-05	0.000203	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—kidney cancer	4.27e-05	0.000201	CcSEcCtD
Clopidogrel—Nausea—Paclitaxel—kidney cancer	4.24e-05	0.0002	CcSEcCtD
Clopidogrel—Asthenia—Capecitabine—kidney cancer	4.2e-05	0.000198	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—kidney cancer	4.15e-05	0.000196	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—kidney cancer	4.15e-05	0.000195	CcSEcCtD
Clopidogrel—Pruritus—Capecitabine—kidney cancer	4.14e-05	0.000195	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—kidney cancer	4.14e-05	0.000195	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—kidney cancer	4.09e-05	0.000192	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—kidney cancer	4.06e-05	0.000191	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—kidney cancer	4.03e-05	0.00019	CcSEcCtD
Clopidogrel—Diarrhoea—Capecitabine—kidney cancer	4e-05	0.000189	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—kidney cancer	3.99e-05	0.000188	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—kidney cancer	3.94e-05	0.000185	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—kidney cancer	3.94e-05	0.000185	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—kidney cancer	3.94e-05	0.000185	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—kidney cancer	3.92e-05	0.000185	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.91e-05	0.000184	CcSEcCtD
Clopidogrel—Dizziness—Capecitabine—kidney cancer	3.87e-05	0.000182	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—kidney cancer	3.8e-05	0.000179	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—kidney cancer	3.77e-05	0.000178	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—kidney cancer	3.77e-05	0.000178	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—kidney cancer	3.75e-05	0.000177	CcSEcCtD
Clopidogrel—Vomiting—Capecitabine—kidney cancer	3.72e-05	0.000175	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—kidney cancer	3.71e-05	0.000175	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—kidney cancer	3.7e-05	0.000174	CcSEcCtD
Clopidogrel—Rash—Capecitabine—kidney cancer	3.69e-05	0.000174	CcSEcCtD
Clopidogrel—Dermatitis—Capecitabine—kidney cancer	3.69e-05	0.000174	CcSEcCtD
Clopidogrel—Headache—Capecitabine—kidney cancer	3.67e-05	0.000173	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—kidney cancer	3.66e-05	0.000173	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—kidney cancer	3.53e-05	0.000166	CcSEcCtD
Clopidogrel—Nausea—Capecitabine—kidney cancer	3.48e-05	0.000164	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.44e-05	0.000162	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—kidney cancer	3.41e-05	0.000161	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—kidney cancer	3.39e-05	0.00016	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—kidney cancer	3.36e-05	0.000158	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—kidney cancer	3.32e-05	0.000156	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.26e-05	0.000153	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—kidney cancer	3.25e-05	0.000153	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—kidney cancer	3.23e-05	0.000152	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—kidney cancer	3.23e-05	0.000152	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—kidney cancer	3.11e-05	0.000146	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—kidney cancer	3.08e-05	0.000145	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—kidney cancer	3e-05	0.000141	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—kidney cancer	2.98e-05	0.00014	CcSEcCtD
Clopidogrel—Abdominal pain—Doxorubicin—kidney cancer	2.98e-05	0.00014	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—kidney cancer	2.78e-05	0.000131	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—kidney cancer	2.71e-05	0.000128	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—kidney cancer	2.67e-05	0.000126	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—kidney cancer	2.58e-05	0.000122	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—kidney cancer	2.49e-05	0.000118	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—kidney cancer	2.4e-05	0.000113	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—kidney cancer	2.38e-05	0.000112	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—kidney cancer	2.38e-05	0.000112	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—kidney cancer	2.36e-05	0.000111	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—kidney cancer	2.24e-05	0.000106	CcSEcCtD
Clopidogrel—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.27e-05	0.000344	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—MAPK3—kidney cancer	1.27e-05	0.000344	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.27e-05	0.000344	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.27e-05	0.000344	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—POMC—kidney cancer	1.26e-05	0.000342	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.26e-05	0.000341	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.25e-05	0.000339	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PPAT—kidney cancer	1.25e-05	0.000339	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CA2—kidney cancer	1.25e-05	0.000338	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—BRAF—kidney cancer	1.25e-05	0.000338	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.24e-05	0.000336	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.24e-05	0.000335	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.23e-05	0.000333	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.23e-05	0.000332	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PGK1—kidney cancer	1.22e-05	0.00033	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.22e-05	0.00033	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ALAD—kidney cancer	1.22e-05	0.000329	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—MAPK1—kidney cancer	1.21e-05	0.000327	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—LDHB—kidney cancer	1.2e-05	0.000324	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SLC5A3—kidney cancer	1.19e-05	0.000322	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PGK1—kidney cancer	1.19e-05	0.000322	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PDHB—kidney cancer	1.19e-05	0.000321	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.19e-05	0.000321	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—POMC—kidney cancer	1.18e-05	0.00032	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—LDHB—kidney cancer	1.17e-05	0.000316	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CRABP1—kidney cancer	1.17e-05	0.000316	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—APRT—kidney cancer	1.17e-05	0.000316	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—FH—kidney cancer	1.17e-05	0.000316	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CA9—kidney cancer	1.16e-05	0.000315	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.16e-05	0.000314	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—PIK3CA—kidney cancer	1.16e-05	0.000313	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—KRAS—kidney cancer	1.14e-05	0.000309	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CRABP1—kidney cancer	1.14e-05	0.000309	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.14e-05	0.000308	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.14e-05	0.000307	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CCBL1—kidney cancer	1.12e-05	0.000302	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.11e-05	0.000301	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PGK1—kidney cancer	1.11e-05	0.000301	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.11e-05	0.0003	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GPC3—kidney cancer	1.1e-05	0.000297	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—LDHB—kidney cancer	1.09e-05	0.000295	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ITPR2—kidney cancer	1.09e-05	0.000294	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CA2—kidney cancer	1.07e-05	0.000289	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ITPR2—kidney cancer	1.06e-05	0.000287	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.05e-05	0.000284	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PIK3CA—kidney cancer	1.05e-05	0.000284	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—RAF1—kidney cancer	1.04e-05	0.000282	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALAD—kidney cancer	1.04e-05	0.000281	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CA9—kidney cancer	1.04e-05	0.000281	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—RELA—kidney cancer	1.04e-05	0.000281	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ERBB2—kidney cancer	1.03e-05	0.000279	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.02e-05	0.000276	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MTOR—kidney cancer	1.02e-05	0.000275	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.01e-05	0.000275	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.01e-05	0.000274	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CA9—kidney cancer	1.01e-05	0.000274	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	9.99e-06	0.00027	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALDH1A1—kidney cancer	9.92e-06	0.000268	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTT1—kidney cancer	9.9e-06	0.000268	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ACHE—kidney cancer	9.9e-06	0.000268	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CRABP1—kidney cancer	9.88e-06	0.000267	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PPAT—kidney cancer	9.68e-06	0.000262	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GLIPR1—kidney cancer	9.68e-06	0.000262	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTT1—kidney cancer	9.67e-06	0.000262	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ACHE—kidney cancer	9.67e-06	0.000262	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN1B—kidney cancer	9.54e-06	0.000258	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SLC5A3—kidney cancer	9.51e-06	0.000257	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PGK1—kidney cancer	9.51e-06	0.000257	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CA9—kidney cancer	9.46e-06	0.000256	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	9.44e-06	0.000255	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—SCARB1—kidney cancer	9.37e-06	0.000254	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL2—kidney cancer	9.34e-06	0.000253	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—LDHB—kidney cancer	9.32e-06	0.000252	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTGS1—kidney cancer	9.27e-06	0.000251	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.24e-06	0.00025	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ITPR2—kidney cancer	9.19e-06	0.000249	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—SCARB1—kidney cancer	9.16e-06	0.000248	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCND1—kidney cancer	9.1e-06	0.000246	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PSMD7—kidney cancer	9.09e-06	0.000246	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—JUN—kidney cancer	9.09e-06	0.000246	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTGS1—kidney cancer	9.06e-06	0.000245	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CTNNB1—kidney cancer	9.02e-06	0.000244	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—FH—kidney cancer	9e-06	0.000244	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—APRT—kidney cancer	9e-06	0.000244	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PSMD7—kidney cancer	8.89e-06	0.000241	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CRABP1—kidney cancer	8.82e-06	0.000239	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PTEN—kidney cancer	8.79e-06	0.000238	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	8.67e-06	0.000235	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—BCHE—kidney cancer	8.62e-06	0.000233	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CRABP1—kidney cancer	8.61e-06	0.000233	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—SLC5A5—kidney cancer	8.52e-06	0.00023	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.47e-06	0.000229	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GPC3—kidney cancer	8.46e-06	0.000229	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—BCHE—kidney cancer	8.43e-06	0.000228	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	8.39e-06	0.000227	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTT1—kidney cancer	8.38e-06	0.000227	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ACHE—kidney cancer	8.38e-06	0.000227	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—SLC5A5—kidney cancer	8.32e-06	0.000225	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CA2—kidney cancer	8.23e-06	0.000223	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—SLC2A1—kidney cancer	8.22e-06	0.000223	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ITPR2—kidney cancer	8.2e-06	0.000222	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CA9—kidney cancer	8.08e-06	0.000219	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CRABP1—kidney cancer	8.04e-06	0.000218	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—SLC2A1—kidney cancer	8.04e-06	0.000218	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALAD—kidney cancer	8.02e-06	0.000217	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ITPR2—kidney cancer	8e-06	0.000217	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VEGFA—kidney cancer	7.94e-06	0.000215	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SCARB1—kidney cancer	7.93e-06	0.000215	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.9e-06	0.000214	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTGS1—kidney cancer	7.85e-06	0.000212	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.83e-06	0.000212	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PSMD7—kidney cancer	7.7e-06	0.000208	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.65e-06	0.000207	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.56e-06	0.000205	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MAPK3—kidney cancer	7.51e-06	0.000203	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ACHE—kidney cancer	7.48e-06	0.000202	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTT1—kidney cancer	7.48e-06	0.000202	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ITPR2—kidney cancer	7.48e-06	0.000202	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PGK1—kidney cancer	7.34e-06	0.000199	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.34e-06	0.000199	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—kidney cancer	7.3e-06	0.000198	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTT1—kidney cancer	7.3e-06	0.000198	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ACHE—kidney cancer	7.3e-06	0.000198	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—BCHE—kidney cancer	7.3e-06	0.000198	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SLC5A5—kidney cancer	7.21e-06	0.000195	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—LDHB—kidney cancer	7.19e-06	0.000195	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MAPK1—kidney cancer	7.14e-06	0.000193	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SCARB1—kidney cancer	7.08e-06	0.000192	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTGS1—kidney cancer	7.01e-06	0.00019	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SLC2A1—kidney cancer	6.96e-06	0.000188	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SCARB1—kidney cancer	6.91e-06	0.000187	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.89e-06	0.000187	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CRABP1—kidney cancer	6.87e-06	0.000186	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PSMD7—kidney cancer	6.87e-06	0.000186	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTP1—kidney cancer	6.86e-06	0.000186	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTGS1—kidney cancer	6.84e-06	0.000185	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTT1—kidney cancer	6.82e-06	0.000185	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ACHE—kidney cancer	6.82e-06	0.000185	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.76e-06	0.000183	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—KRAS—kidney cancer	6.75e-06	0.000183	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PSMD7—kidney cancer	6.71e-06	0.000182	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTP1—kidney cancer	6.7e-06	0.000181	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—BCHE—kidney cancer	6.51e-06	0.000176	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ABCB1—kidney cancer	6.49e-06	0.000176	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SCARB1—kidney cancer	6.45e-06	0.000175	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SLC5A5—kidney cancer	6.43e-06	0.000174	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ITPR2—kidney cancer	6.39e-06	0.000173	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTGS1—kidney cancer	6.39e-06	0.000173	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—BCHE—kidney cancer	6.36e-06	0.000172	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ABCB1—kidney cancer	6.35e-06	0.000172	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTM1—kidney cancer	6.3e-06	0.000171	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SLC5A5—kidney cancer	6.28e-06	0.00017	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PSMD7—kidney cancer	6.27e-06	0.00017	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CA9—kidney cancer	6.24e-06	0.000169	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SLC2A1—kidney cancer	6.21e-06	0.000168	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CA—kidney cancer	6.2e-06	0.000168	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTM1—kidney cancer	6.16e-06	0.000167	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SLC2A1—kidney cancer	6.07e-06	0.000164	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.03e-06	0.000163	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—kidney cancer	6e-06	0.000162	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP1A1—kidney cancer	5.98e-06	0.000162	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—BCHE—kidney cancer	5.94e-06	0.000161	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.89e-06	0.000159	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.89e-06	0.000159	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SLC5A5—kidney cancer	5.87e-06	0.000159	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP1A1—kidney cancer	5.84e-06	0.000158	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ACHE—kidney cancer	5.83e-06	0.000158	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTT1—kidney cancer	5.83e-06	0.000158	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTP1—kidney cancer	5.81e-06	0.000157	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.78e-06	0.000157	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.67e-06	0.000153	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SCARB1—kidney cancer	5.52e-06	0.000149	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.5e-06	0.000149	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ABCB1—kidney cancer	5.5e-06	0.000149	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTGS1—kidney cancer	5.46e-06	0.000148	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PSMD7—kidney cancer	5.35e-06	0.000145	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTM1—kidney cancer	5.34e-06	0.000144	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CRABP1—kidney cancer	5.3e-06	0.000144	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.26e-06	0.000142	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTP1—kidney cancer	5.18e-06	0.00014	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—BCHE—kidney cancer	5.08e-06	0.000137	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTP1—kidney cancer	5.06e-06	0.000137	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.06e-06	0.000137	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.01e-06	0.000136	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ITPR2—kidney cancer	4.93e-06	0.000133	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ABCB1—kidney cancer	4.91e-06	0.000133	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SLC2A1—kidney cancer	4.84e-06	0.000131	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.79e-06	0.00013	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTM1—kidney cancer	4.76e-06	0.000129	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTP1—kidney cancer	4.73e-06	0.000128	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.7e-06	0.000127	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTM1—kidney cancer	4.65e-06	0.000126	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP1A1—kidney cancer	4.52e-06	0.000122	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTT1—kidney cancer	4.5e-06	0.000122	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ACHE—kidney cancer	4.5e-06	0.000122	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ABCB1—kidney cancer	4.47e-06	0.000121	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—POMC—kidney cancer	4.46e-06	0.000121	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP1A1—kidney cancer	4.41e-06	0.000119	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—POMC—kidney cancer	4.35e-06	0.000118	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTM1—kidney cancer	4.34e-06	0.000118	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SCARB1—kidney cancer	4.26e-06	0.000115	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTGS1—kidney cancer	4.21e-06	0.000114	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.16e-06	0.000112	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PSMD7—kidney cancer	4.13e-06	0.000112	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.12e-06	0.000111	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.1e-06	0.000111	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTP1—kidney cancer	4.04e-06	0.000109	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—BCHE—kidney cancer	3.92e-06	0.000106	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.87e-06	0.000105	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ABCB1—kidney cancer	3.82e-06	0.000103	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—POMC—kidney cancer	3.77e-06	0.000102	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.74e-06	0.000101	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTM1—kidney cancer	3.71e-06	0.0001	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.71e-06	0.0001	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTGS2—kidney cancer	3.55e-06	9.62e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.52e-06	9.52e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTGS2—kidney cancer	3.47e-06	9.4e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.38e-06	9.15e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—POMC—kidney cancer	3.37e-06	9.11e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—POMC—kidney cancer	3.29e-06	8.89e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTP1—kidney cancer	3.12e-06	8.44e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTEN—kidney cancer	3.1e-06	8.39e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—POMC—kidney cancer	3.07e-06	8.31e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTEN—kidney cancer	3.03e-06	8.2e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTGS2—kidney cancer	3.01e-06	8.14e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ABCB1—kidney cancer	2.95e-06	7.99e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.89e-06	7.82e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTM1—kidney cancer	2.86e-06	7.75e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.72e-06	7.35e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTGS2—kidney cancer	2.69e-06	7.27e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTEN—kidney cancer	2.62e-06	7.1e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—POMC—kidney cancer	2.62e-06	7.1e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTGS2—kidney cancer	2.62e-06	7.09e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTGS2—kidney cancer	2.45e-06	6.63e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTEN—kidney cancer	2.34e-06	6.34e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTEN—kidney cancer	2.29e-06	6.19e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CA—kidney cancer	2.19e-06	5.92e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.14e-06	5.78e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTEN—kidney cancer	2.14e-06	5.78e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTGS2—kidney cancer	2.09e-06	5.66e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—POMC—kidney cancer	2.02e-06	5.48e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.85e-06	5.01e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTEN—kidney cancer	1.82e-06	4.94e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.65e-06	4.47e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTGS2—kidney cancer	1.61e-06	4.37e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CA—kidney cancer	1.61e-06	4.36e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.51e-06	4.08e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTEN—kidney cancer	1.41e-06	3.81e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.29e-06	3.48e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.93e-07	2.69e-05	CbGpPWpGaD
